{"id":"NCT00667446","sponsor":"AbbVie (prior sponsor, Abbott)","briefTitle":"Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty","officialTitle":"A 36 Month, Multi-Center, Open-Label Extension Study to Evaluate the Safety of Leuprolide Acetate 11.25 mg and 30 mg Formulations in Children With Central Precocious Puberty","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-12","primaryCompletion":"2012-10","completion":"2013-01","firstPosted":"2008-04-28","resultsPosted":"2013-12-10","lastUpdate":"2014-01-09"},"enrollment":72,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Precocious","Leuprolide Acetate","Luteinizing Hormone (LH)","Gonadotrophin-releasing Hormone Agonist (GnRHa)","Tanner Staging","Depot Formulation","Suppression of LH","Central Precocious Puberty (CPP)","Gonadotrophin-releasing Hormone (GnRH)","Lupron","GnRH Analog","Pediatrics Central Precocious Puberty"],"interventions":[{"type":"DRUG","name":"Leuprolide Acetate 3 Month Depot","otherNames":["ABT-818","Lupron","Leuprorelin acetate"]}],"arms":[{"label":"Leuprolide Acetate 3M Depot 11.25 mg","type":"EXPERIMENTAL"},{"label":"Leuprolide Acetate 3M Depot 30 mg","type":"EXPERIMENTAL"}],"summary":"The purpose of this extension study is to determine if leuprolide acetate (11.25 mg and 30 mg) is safe in treating children with Central Precocious Puberty over a longer period of time (36 months).","primaryOutcome":{"measure":"Percentage of Participants With Suppression of Peak-Stimulated Luteinizing Hormone","timeFrame":"Day 1, Months 6, 12, 24, and 36","effectByArm":[{"arm":"Leuprolide Acetate 3M Depot 11.25 mg","deltaMin":96.9,"sd":null},{"arm":"Leuprolide Acetate 3M Depot 30 mg","deltaMin":100,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":10},"locations":{"siteCount":20,"countries":["United States","Puerto Rico"]},"refs":{"pmids":["24926950"],"seeAlso":["http://rxabbvie.com"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":34},"commonTop":["INJECTION SITE PAIN","UPPER RESPIRATORY TRACT INFECTION","COUGH","PYREXIA","HEADACHE"]}}